Back to Search
WILLIAM MCMASTER, M.D.
M.D.
Thoracic Surgery (Cardiothoracic Vascular Surgery) Physician
NPI: 1124345574IndividualAccepts Medicare
Specialties, Licenses & Credentials
Thoracic Surgery (Cardiothoracic Vascular Surgery) PhysicianPrimary
Thoracic Surgery (Cardiothoracic Vascular Surgery)
Code: 208G00000X
50674(TN)89449(SC)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Education
MEDICAL UNIVERSITY OF SOUTH CAROLINA COLLEGE OF MEDICINE
Class of 2010
Research & Publications (20)
Antimicrobial peptide-induced apoptotic death of leishmania results from calcium-de pend ent, caspase-independent mitochondrial toxicity.
PMID 19357081·J Biol Chem·2009
7-preclinical
In vitro quantitative assessment of total and bipolar shoulder arthroplasties: a biomechanical study using human cadaver shoulders.
PMID 19501938·Clin Biomech (Bristol)·2009
8-other
The role of liposome charge on immune response generated in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63).
PMID 19211022·Exp Parasitol·2009
7-preclinical
Enhancement of immune response and protection in BALB/c mice immunized with liposomal recombinant major surface glycoprotein of Leishmania (rgp63): the role of bilayer composition.
PMID 19615870·Colloids Surf B Biointerfaces·2009
7-preclinical
The Leishmania surface protease GP63 cleaves multiple intracellular proteins and actively participates in p38 mitogen-activated protein kinase inactivation.
PMID 19064994·J Biol Chem·2009
7-preclinical
Leishmania surface protein gp63 binds directly to human natural killer cells and inhibits proliferation.
PMID 18713141·Clin Exp Immunol·2008
7-preclinical
AOA Symposium. Barriers (threats) to clinical research.
PMID 18676910·J Bone Joint Surg Am·2008
6-review
Increased endovascular interventions decrease the rate of lower limb artery bypass operations without an increase in major amputation rate.
PMID 18346571·Ann Vasc Surg·2008
8-other
Fibronectin binding and proteolytic degradation by Leishmania and effects on macrophage activation.
PMID 18212076·Infect Immun·2008
7-preclinical
MDQC: a new quality assessment method for microarrays based on quality control reports.
PMID 17933854·Bioinformatics·2007
8-other
The role of CpG ODN in enhancement of immune response and protection in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63) encapsulated in cationic liposome.
PMID 17629372·Vaccine·2007
7-preclinical
Leishmania major abrogates gamma interferon-induced gene expression in human macrophages from a global perspective.
PMID 17470541·Infect Immun·2007
7-preclinical
Regions in the 3' untranslated region confer stage-specific expression to the Leishmania mexicana a600-4 gene.
PMID 17433460·Mol Biochem Parasitol·2007
7-preclinical
Genomic and proteomic expression analysis of Leishmania promastigote and amastigote life stages: the Leishmania genome is constitutively expressed.
PMID 17188763·Mol Biochem Parasitol·2007
4-observational
The major surface-metalloprotease of the parasitic protozoan, Leishmania, protects against antimicrobial peptide-induced apoptotic killing.
PMID 17074074·Mol Microbiol·2006
7-preclinical
Expression profiling by whole-genome interspecies microarray hybridization reveals differential gene expression in procyclic promastigotes, lesion-derived amastigotes, and axenic amastigotes in Leishmania mexicana.
PMID 16430978·Mol Biochem Parasitol·2006
4-observational
Immune response and protection assay of recombinant major surface glycoprotein of Leishmania (rgp63) reconstituted with liposomes in BALB/c mice.
PMID 16740346·Vaccine·2006
7-preclinical
The conduct of clinical research under the HIPAA Privacy Rule.
PMID 17142429·J Bone Joint Surg Am·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 8 RICHLAND MEDICAL PARK DR STE 400
COLUMBIA, SC 29203 - Phone
- (803) 795-0871
Quick Facts
- NPI
- 1124345574
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 2
- Years in Practice
- 16
- Publications
- 20
Are you this provider?
Claim Your Profile